A phase I study of gemcitabine, capecitabine, and vandetanib in patients with advanced solid tumors with an expanded cohort in biliary and pancreatic malignancies

被引：0
|
作者：
Nallapareddy, S.
Eckhardt, S. G.
O'Bryant, C. L.
Eppers, S.
Diab, S.
Kane, M. A.
Weekes, C. D.
Spratlin, J. L.
Messersmith, W. A.
Leong, S.
机构：
[1] Univ Colorado, Ctr Canc, Aurora, CO USA
[2] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.2535
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2535
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [1] A phase I study of gemcitabine, capecitabine and vandetanib in patients with advanced solid tumors with an expanded cohort in billary and pancreatic malignancies
    Leong, S.
    Obryant, C. L.
    Messersmith, W. A.
    Diab, S.
    Kane, M. A.
    Nallapreddy, S.
    Weekes, C.
    Spratlin, J.
    Call, J.
    Eckhardt, S. G.
    EJC SUPPLEMENTS, 2008, 6 (12): : 126 - 126
  • [2] Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers
    Kessler, Elizabeth R.
    Eckhardt, S. Gail
    Pitts, Todd M.
    Bradshaw-Pierce, Erica L.
    O'byrant, Cindy L.
    Messersmith, Wells A.
    Nallapreddy, Sujatha
    Weekes, Colin
    Spratlin, Jennifer
    Lieu, Christopher H.
    Kane, Madeleine A.
    Eppers, Sarah
    Freas, Elizabeth
    Leong, Stephen
    INVESTIGATIONAL NEW DRUGS, 2016, 34 (02) : 176 - 183
  • [3] Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers
    Elizabeth R. Kessler
    S. Gail Eckhardt
    Todd M. Pitts
    Erica L. Bradshaw-Pierce
    Cindy L. O’byrant
    Wells A. Messersmith
    Sujatha Nallapreddy
    Colin Weekes
    Jennifer Spratlin
    Christopher H. Lieu
    Madeleine A. Kane
    Sarah Eppers
    Elizabeth Freas
    Stephen Leong
    Investigational New Drugs, 2016, 34 : 176 - 183
  • [4] Phase I trial of sorafenib and gemcitabine in advanced solid tumors with an expanded cohort in advanced pancreatic cancer
    Siu, LL
    Awada, A
    Takimoto, CH
    Piccart, M
    Schwartz, B
    Giannaris, T
    Lathia, C
    Petrenciuc, O
    Moore, MJ
    CLINICAL CANCER RESEARCH, 2006, 12 (01) : 144 - 151
  • [5] Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer
    Riechelmann, Rachel R.
    Townsley, Carol A.
    Chin, Sheray N.
    Pond, Gregory R.
    Knox, Jennifer J.
    CANCER, 2007, 110 (06) : 1307 - 1312
  • [6] A phase I study, with expanded cohort, of biweekly fixed-dose rate gemcitabine (FDR GEM) plus capecitabine (CAP) in patients with advanced pancreatic (APC) and biliary carcinomas (ABC)
    Espinoza, A. M.
    Ko, A. H.
    Venook, A. P.
    Bergsland, E. K.
    Jones, K. A.
    Kelley, R. K.
    Korn, W. M.
    Dito, E.
    Ong, A.
    Tempero, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Phase I study of fixed-dose rate (FDR) gemcitabine with capecitabine in advanced solid malignancies
    Attia, S.
    Eickhoff, J.
    Holen, K. D.
    Bailey, H.
    Alberti, D.
    Wilding, G.
    Liu, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Phase I study of piritrexim and gemcitabine in patients with advanced solid tumors
    Huie, M
    Carducci, M
    Liu, G
    Wilding, GG
    Marnocha, R
    Izquierda, M
    Thomas, J
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (06): : 613 - 617
  • [9] Phase I study on docetaxel and Gemcitabine in patients with advanced solid tumors
    Jaremtchuk, AV
    Zarba, JJ
    Ferro, A
    ANNALS OF ONCOLOGY, 1998, 9 : 138 - 139
  • [10] Expanded phase I study of vorinostat (VOR) in combination with capecitabine (CAP) in patients (pts) with advanced solid tumors
    Townsley, C.
    Oza, A. M.
    Tang, P.
    Siu, L. L.
    Pond, G. R.
    Sarveswaran, P.
    Webster, S.
    Zwiebel, J. A.
    Chen, E. X.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345